PMVP Key Financial Ratios - PMV Pharmaceuticals, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	7.7	—	-91.66%	-105.20%
2026-03-31	11.14	—	-81.13%	-89.06%
2025-12-31	10.09	—	-66.70%	-74.24%
2025-09-30	10.76	—	-61.79%	-68.35%
2025-06-30	12.52	—	-52.91%	-57.52%
2025-03-31	16.75	—	-35.68%	-38.02%
2024-12-31	12.22	—	-30.69%	-33.34%
2024-09-30	13.98	—	-23.03%	-26.00%
2024-06-30	19.22	—	-20.58%	-22.81%
2024-03-31	16.79	—	-27.48%	-30.61%
2023-12-31	14.78	—	-27.35%	-30.56%
2023-09-30	19.16	—	-27.79%	-30.53%
2023-06-30	16.63	—	-30.61%	-34.04%
2023-03-31	22.03	—	-29.14%	-32.15%
2022-12-31	22.8	—	-27.12%	-29.80%
2022-09-30	22.75	—	-25.38%	-27.69%
2022-06-30	24.76	—	-22.99%	-24.95%
2022-03-31	24.65	—	-20.53%	-22.16%
2021-12-31	24.66	—	-17.45%	-18.75%
2021-09-30	36.62	—	-14.51%	-15.37%
2021-06-30	43.05	—	-12.28%	-12.93%
2021-03-31	57.79	—	-10.94%	-11.14%
2020-12-31	56.9	—	-9.42%	-9.59%
2020-09-30	68.24	—	-8.29%	-8.41%
2020-06-30	—	—	—	33.46%
2020-03-31	—	—	—	34.32%
2019-12-31	22.57	—	-24.61%	35.97%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	10.09	—	-66.70%	-74.24%
2024-12-31	12.22	—	-30.69%	-33.34%
2023-12-31	14.78	—	-27.35%	-30.56%
2022-12-31	22.8	—	-27.12%	-29.80%
2021-12-31	24.66	—	-17.45%	-18.75%
2020-12-31	56.9	—	-9.42%	-9.59%
2019-12-31	22.57	—	-24.61%	35.97%
2018-12-31	—	—	—	38.01%